Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 7, 2012 - Issue 6
Submit an article Journal homepage
64
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Ocular manifestations of chronic kidney disease among adult patients receiving hemodialysis

Oteri Eme Okolo University of Benin Teaching Hospital, PMB 1111, Benin City, Nigeria
&
Afekhide Ernest Omoti University of Benin Teaching Hospital, PMB 1111, Benin City, Nigeria. [email protected]
Pages 517-528 | Published online: 09 Jan 2014

References

  • Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 72(3), 247–259 (2007).
  • Arrigo S, Guiseppe R. Chronic renal disease as a public health problem: Epidemiology, social, and economic implications. Kidney Int. 68(98) 7–10 (2005).
  • Bajracharya L, Shah DN, Raut KB, Koirala S. Ocular evaluation in patients with chronic renal failure – a hospital based study. Nepal Med. Coll. J. 10(4), 209–214 (2008).
  • Dinc UA, Ozdek S, Aktas Z, Guz G, Onol M. Changes in intraocular pressure, and corneal and retinal nerve fiber layer thickness during hemodialysis. Int. Ophthalmol. 30(4), 337–340 (2010).
  • Alireza G, Tooraj C. Effects of noxious compounds in exhaled breath air as a potential mechanism causing ‘red eye’ in renal failure patients. Iran J. Med. Hypothesis Ideas 1(68), 7–8 (2007).
  • Evans RD, Rosner M. Ocular abnormalities associated with advanced kidney disease and hemodialysis. Semin. Dial. 18(3), 252–257 (2005).
  • Vrabec R, Vatavuk Z, Pavlovic D et al. Ocular findings in patients with chronic renal failure undergoing hemodialysis. Coll. Antropol. 29(1), 95–98 (2005).
  • Grunwald JE, Alexander J, Maguire M et al.; CRIC Study Group. Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5(5), 867–873 (2010).
  • Baker LRI. Renal disease. In: Clinical Medicine (4th Edition) WB Saunders, Edinburg, TX, USA 519–596 (1999).
  • Ndiaye Sow MN, Wane AM, Ka AM et al. Ocular lesions in melanodermia patients with chronic renal failure. Mali Med. 25(4), 14–20 (2010).
  • Abrams JD. Corneal and other ocular findings inpatients on intermittent dialysis for renal failure. Roy. Soc. Med. Proc. 59, 533–536 (1966).
  • Graff P de, Polack BCP, Wolff D de, Schicht IM, Oosterhuis JA, Graff J de. Ocular calcification in dialysis patients. Metabol. Ped. Ophthalmol. 4, 73–77 (1980).
  • Klaassen-Broekema N, van Bijsterveld OP. Red eyes in renal failure. Br. J. Ophthalmol. 76(5), 268–271 (1992).
  • Aktas Z, Ozdek S, Asli Dinç U et al. Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure. Nephrology (Carlton) 12(4), 380–385 (2007).
  • Akinsola A, Durosinmi MO, Akinola NO. The hematological profile of Nigerians with chronic renal failure. Afr. J. Med. Med. Sci. 29(1), 13–16 (2009).
  • Dilek D, Beyhan D, Sibel O, Pinar A. Impression cytology of the conjunctival epithelium in patients with chronic renal failure. Br. J. Ophthalmol. 84(11) 1225–1227 (2000).
  • Vannucchi MT, Vannucchi H, Humphreys M. Serum levels of vitamin A and retinol binding protein in chronic renal failure patients treated by continuous ambulatorial peritoneal dialysis. Int. J. Vit. and Nut. Research 62(2), 107–112 (1992).
  • Demir N, Altay M, Ozer E et al. Duration of renal failure as risk factor for conjunctival squamous metaplasia. Acta Cytol. 52(3), 309–312 (2008).
  • Ozdemir M, Bakaris S, Ozdemir G, Buyukbese MA, Cetinkaya A. Ocular surface disorders and tear function changes in patients with chronic renal failure. Can. J. Ophthalmol. 39(5), 526–532 (2004).
  • Charlton JF, Schwab IR, Stuchell R. Tear hyperosmolarity in renal dialysis patients asymptomatic for dry eye. Cornea 15(4), 335–339 (1996).
  • Seyahi N, Altiparmak MR, Kahveci A et al. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients. Ophthalmol. 92(1) 62–70 (1985).
  • Patel DV, Snead MP, Satchi K. Retinal arteriolar calcification in a patient with chronic renal failure. Br. J. Ophthalmol. 86(9), 1063 (2002).
  • Klaassen-Broekema N, van Bijsterveld OP. Limbal and corneal calcification in patients with chronic renal failure. Br. J. Ophthalmol. 77(9), 569–571 (1993).
  • Bourquia A, Zaghloul K, Berrada S et al. Ocular calcification in hemodialysis patients. Ann. Med. Interne. 143, 351–354 (1992).
  • Tokuyama T, Ikeda T, Sato K, Mimura O, Morita A, Tabata T. Conjunctival and corneal calcification and bone metabolism in hemodialysis patients. Am. J. Kidney Dis. 39(2), 291–296 (2002).
  • Radovan H, Dusica P. Intraocular pressure in chronic renal failure patients treated with maintainance hemodialysis. Ophthalmologica 211(6), 325–326 (1997).
  • Ching-His H, Anning C, Sung Yu C et al. Association of severity of conjunctival and corneal calcfciation with all-cause 1-year mortality in maintenance hemodialysis patients. Nephrol. D. Tranpl. 3(26) 1016–1023 (2010).
  • Nakanome S, Watanabe H, Tanaka K, Tochikubo T. Calcification of Hydroview H60M intraocular lenses: aqueous humor analysis and comparisons with other intraocular lens materials. J. Cataract Refract. Surg. 34(1), 80–86 (2008).
  • Gartaganis SP, Kanellopoulou DG, Mela EK, Panteli VS, Koutsoukos PG. Opacification of hydrophilic acrylic intraocular lens attributable to calcification: investigation on mechanism. Am. J. Ophthalmol. 146(3), 395–403 (2008).
  • Liliana W. Calcification of hydrophilic acrylic intraocular lenses. Am. J. Ophthalmol. 146(3), 341–343 (2008).
  • Daniel HW, Tien WY, Paul JF, Wan-Ting T, Seang-Mei S, Tin A. Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study. Am. J. Ophthalmol. 147(4), 709–716 (2009).
  • Nobuyuki O, Mamoru M, Masakatsu F. Corneal endothelial changes in patients with chronic renal failure. Am. J. Ophthalmol. 128(2), 234–236 (1999).
  • Diaz-Couchoud P, Bordas FD, Garcia JR, Camps EM, Carceller A. Corneal disease in patients with chronic renal insufficiency undergoing hemodialysis. Cornea 20(7), 695–702 (2001).
  • Easterbrook M, Mortimer CB. Ocular signs in chronic renal failure. Br. J. Ophthalmol. 54(11), 724–730 (1970).
  • Monisha EN, Tien YW, Charumathi S, Su-Chi L, E-Shyong T, Tin A. Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study. Ophthalmol. 117(3), 477–483 (2010).
  • Sitprija V, Holmes JH, Ellis PP. Changes in intraocular pressure during hemodialysis. Invest. Ophthalmol. 3, 273–284 (1964).
  • Takanobu T, Tomohiro I, Keiko S. Effect of plasma colloid osmotic pressure on intraocular pressure during hemodialysis. Br. J. Ophthalmol. 82(7) 751–753 (1998).
  • Ibrahim S, Sami D, Nabil A. The effect of hemodialysis on colloid osmotic pressure and intraocular pressure. JRMS 9(2), 27–29 (2002).
  • Nagaoka T, Takeyama Y, Kanagawa S, Sakagami K, Mori F, Yoshida A. Effect of haemodialysis on retinal circulation in patients with end-stage renal disease. Br. J. Ophthalmol. 88(8), 1026–1029 (2004).
  • Burn RA. Intraocular pressure during haemodialysis. Br. J. Ophthalmol. 57(7), 511–513 (1973).
  • Dominik MF, Johanes F, Gerald K, Mathias HA. Rise in intraocular pressure in a patient with reduced outflow facility. Br. J. Ophthalmol. 91(8), 1091–1092 (2007).
  • Doshiro A, Ban Y, Kobayashi L, Yoshida Y, Uchiyama H. Intraocular pressure change during hemodialysis. Am. J. Ophthalmol. 142(2), 337–339 (2006).
  • Carolina PB, Fransisco RS, Fernando P et al Intraocular pressure and ocular perfusion during hemodialysis. Arq. Bras. Oftalmol. 74(2), 255–260 (2011).
  • Tawara A, Kobata H, Fujisawa K, Abe T, Ohnishi Y. Mechanism of intraocular pressure elevation during hemodialysis. Curr. Eye Res. 17(4), 339–347 (1998).
  • Won KS, Seung JH, Ho YY, Gong JS, Young JH. Recurrent intraocular pressure elevation during hemodialysis in a patient with neovascular glaucoma. KJO 20(2), 109–112 (2006).
  • Masuda H, Shibuya Y, Ohira A. Markedly increased unilateral intraocular pressure during hemodialysis in a patient with ipsilateral exfoliative glaucoma. Am. J. Ophthalmol. 129(4), 534–536 (2000).
  • Choong YF, Menage MJ. Symptomatic acute raised IOP following hemodialysis in a patient with end-stage renal failure. Br. J. Ophthalmol. 82(11), 1342 (1998).
  • Costagliola C, Mastropasqua L. The influence of hemodialysis on intraocular pressure: III. Aqueous humor dynamics and tissue hydration. Ann. Ophthalmol. 23(1), 31–34 (1991).
  • Pelit A, Zümrütdal A, Akova Y. The effect of hemodialysis on visual field test in patients with chronic renal failure. Curr. Eye Res. 26(5), 303–306 (2003).
  • Austin JN, Klein M, Mishell J et al. Intraocular pressures during high-flux hemodialysis. Ren. Fail. 12(2), 109–112 (1990).
  • Levy J, Tovbin D, Lifshitz T, Zlotnik M, Tessler Z. Intraocular pressure during hemodialysis: a review. Eye 19(12), 1249–1256 (2005).
  • Berlyne GM, Ari JB, Danovitch GM, Blumenthal M. Cataracts of chronic renal failure. Lancet 1(7749), 509–511 (1972).
  • Huyrih OS, Kiliey A, Strippoli GFM, Mitchel P. Is renal impairment a predictor for the incidence of cataract or cataract surgery? Ophthalmology 112(2), 293–300 (2005).
  • Wong TY, Coresh J, Klein R et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J. Am. Soc. Nephrol. 15(9), 2469–2476 (2004).
  • Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br. J. Ophthalmol. 89(12), 1646–1654 (2005).
  • Park HY, Ohn YH, Shin HH, Lee HB. Ocular manifestations in patients with chronic renal failure. J. Korean Ophthalmol. Soc. 38(7), 1280–1288 (1997).
  • Wessing A. Diabetic retinopathy: update on diagnosis and treatment. Nephrol. Dial. Transplant. 12(9), 2013–2018 (1997).
  • Vivekanand JHA. End-stage renal care in developing countries: the India experience. Ren. Fail. 26(3), 201–208 (2004).
  • Bamgboye EL. End-stage renal disease in sub-Saharan Africa. Ethn. Dis. 16(2 Suppl. 2), S2–S5 (2006).
  • Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann. Intern. Med. 124(1 Pt 2), 90–96 (1996).
  • Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med. Clin. North Am. 88(4), 1001–1036, xi (2004).
  • Kanski JJ, Bowling B. Retinal vascular diseases. In: Clinical Ophthalmology: A Systematic Approach (7th Edition). Elsevier Saunders, PA, USA. 13, 534–559 (2011).
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – ETDRS report number 10. Ophthalmology 98(5), 786–806 (1991).
  • Goldstein DA, Massry SG. Diabetic nephropathy: clinical course and effect of hemodialysis. Nephron 20(5), 286–296 (1978).
  • Ishii A, Haruyama K, Funatsu H, Iwamoto I. Trends over time for diabetic retinopathy in diabetic patients with end-stage renal disease. J. Japan Diabetic Society 45(10), 737–742 (2002).
  • Watanabe Y, Yuzawa Y, Mizumoto D et al. Long-term follow-up study of 268 diabetic patients undergoing haemodialysis, with special attention to visual acuity and heterogeneity. Nephrol. Dial. Transplant. 8(8), 725–734 (1993).
  • Ichikawa K, Kanie K, Yoshida N, Kaga T, Nagata A. Diabetic macular edema and hemodialysis therapy. Folia Ophthalmologica Japonica 55(4), 258–264 (2004).
  • Theodossiadis PG, Theodoropoulou S, Neamonitou G et al. Hemodialysis-induced alterations in macular thickness measured by optical coherence tomography in diabetic patients with end-stage renal disease. Ophthalmologica 227(2), 90–94 (2012).
  • Auyanet I, Rodríguez LJ, Bosch E et al. Measurement of foveal thickness by optical coherence tomography in adult haemodialysis patients with diabetic nephropathy. Nefrologia 31(1), 66–69 (2011).
  • Tokuyama T, Ikeda T, Sato K. Effects of haemodialysis on diabetic macular leakage. Br. J. Ophthalmol. 84(12), 1397–1400 (2000).
  • Matsuo T. Disappearance of diabetic macular hard exudates after hemodialysis introduction. Acta Med. Okayama 60(3), 201–205 (2006).
  • Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M et al. Erythropoetin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 353(8), 782–792 (2005).
  • Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure? Am. J. Med. Sci. 334(4), 260–264 (2007).
  • Hayashi H, Kurata Y, Imanaga Y, Goya K, Oshima K. Vitrectomy for diabetic retinopathy in patients undergoing hemodialysis for associated end-stage renal failure. Retina (Philadelphia) 18(2), 156–159 (1998).
  • Arakawa S, Yasuda M, Nagata M et al. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study. Invest. Ophthalmol. Vis. Sci. 52(8), 5905–5909 (2011).
  • Balogh Z, Berta A, Pfliegler G, Nagy V. Bilateral central retinal vein occlusion caused by malignant hypertension in a young patient. Clin. Exp. Hypertens. 33(1), 53–55 (2011).
  • Elgohary M. Hemorheological changes in patients undergoing hemodialysis for chronic renal failure and retinal ischemia. Eye 18(9), 958–959 (2004).
  • Yoav K, Yoav Y, Avi S. Hyperbaric therapy for bilateral visual loss during hemodialysis. Clin. Exp. Nephrol. 10(34), 82–84 (2006).
  • Basri NA, Shaheen FA. Visual loss in uremic patients on dialysis: a case report and review of literature. Saudi J. Kidney Dis. Transpl. 13(1), 45–49 (2002).
  • Prat NM, Sánchez-Dalmau BF, Foroozan R. Not just for men. Surv. Ophthalmol. 56(2), 173–177 (2011).
  • Sabeel A, Al-Hazzaa SA, Alfurayh O, Mikkonen P. The dialysed patient who turned blind during a haemodialysis session. Nephrol. Dial. Transplant. 13(11), 2957–2958 (1998).
  • Tosun O, Davutluoglu B, Arda K et al. Determination of the effect of a single hemodialysis session on retrobulbar blood hemodynamics by color Doppler ultrasonography. Acta Radiol. 48(7), 763–767 (2007).
  • Servilla KS, Groggel GC. Anterior ischemic optic neuropathy as a complication of hemodialysis. Am. J. Kidney Dis. 8(1), 61–63 (1986).
  • Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 132(5), 734–742 (2001).
  • Newman NJ, Scherer R, Langenberg P et al.; Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am. J. Ophthalmol. 134(3), 317–328 (2002).
  • Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 94(8), 1020–1028 (1987).
  • Nieto J, Zapata MA. Bilateral anterior ischemic optic neuropathy in patients on dialysis: a report of two cases. Indian J. Nephrol. 20(1), 48–50 (2010).
  • Leon R, Marinaro C, Cerer D. Previous ischemic optic neuropathy in hemodialysis. Nefrologica 29(6), 614–616 (2009).
  • Basile C, Addabbo G, Montanaro A. Anterior ischemic optic neuropathy and dialysis: role of hypotension and anemia. J. Nephrol. 14(5), 420–423 (2001).
  • Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch. Clin. Exp. Ophthalmol. 245(8), 1107–1121 (2007).
  • Oguz H, Sobaci G. The use of hyperbaric oxygen therapy in ophthalmology. Surv. Ophthalmol. 53(2), 112–120 (2008).
  • Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 122(4), 535–541 (1996).
  • The Ischemic Optic neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic ischemic optic neuropathy is not effective and may be harmful. JAMA 273(8), 625–632 (1995).
  • Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 107(3), 521–526 (2000).
  • Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 123(2), 212–217 (1997).
  • Troiano P, Buccianti G. Bilateral symmetric retinal detachment and multiple retinal pigment epithelial detachments during haemodialysis. Nephrol. Dial. Transplant. 13(8), 2135–2137 (1998).
  • Gass JD. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefes Arch. Clin. Exp. Ophthalmol. 230(5), 454–458 (1992).
  • Liew G, Mitchell P, Wong TY, Iyengar SK, Wang JJ. CKD increases the risk of age-related macular degeneration. J. Am. Soc. Nephrol. 19(4), 806–811 (2008).
  • Wells M, Foroozan R. Transient visual loss may anticipate occipital infarction from hemodialysis. Am. J. Kidney Dis. 43(5), e29–e33 (2004).
  • Al-Falki YH. Bilateral occipital infarcts in a hemodialysis patient. Am. J. Nephrol. 21(5), 413–414 (2001).
  • de Lima LM, Cecchetti SA, Cecchetti DF et al. Endophthalmitis: a rare but devastating metastatic bacterial complication of hemodialysis catheter-related sepsis. Ren. Fail. 34(1), 119–122 (2012).
  • Desai M, Rapoor R, Gudithi SL, Kumar R, Prasad N, Dakshinamurty KV. Endophthalmitis: a rare complication of arteriovenous fistula infection. Hemodial. Int. 12(2), 227–229 (2008).
  • Hutter JC, Kuehnert MJ, Wallis RR, Lucas AD, Sen S, Jarvis WR. Acute onset of decreased vision and hearing traced to hemodialysis treatment with aged dialyzers. JAMA 283(16), 2128–2134 (2000).
  • Oba T, Tsuji K, Nakamura A et al. Migration of acetylated hemicellulose from capillary hemodialyzer to blood, causing scleritis and/or iritis. Artif. Organs 8(4), 429–435 (1984).
  • Jung HL, In TK. The electroretinogram in chronic renal failure. Korean J. Ophthalmol. 12, 68–72 (1998).
  • Russell P, Sekuler R, Roxe D, Messersmith R, Mulvanny P. Contrast sensitivity of hemodialysis patients. Metab. Pediatr. Syst. Ophthalmol. 7(4), 201–206 (1983).
  • Pahor D. Retinal light sensitivity in hemodialysis patients. Eye 17(2), 177–182 (2003).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.